University of Calgary
University of Calgary
Calgary, Alberta, Canada15 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis | Metabolic Dysfunction Associated Steatohepatitis | Recruiting | Phase 3 | 2026-10-01 | NCT06632457 | |
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder | Recruiting | Phase 3 | 2026-10-01 | NCT06632444 | |
| Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Phase 2 | 2026-09-24 | NCT07654283 | |
| Conventional Lead Opposed to Novel ECG (CLONE) | ECG Monitoring | Active, not recruiting | Not stated | 2026-09-17 | NCT07624435 | |
| Subjective Experience Following Psilocybin | Fractures, Stress, bone fracture, injury | Recruiting | Phase 2 | 2026-09-02 | NCT06768944 | |
| Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) | autoimmune pulmonary alveolar proteinosis | Active, not recruiting | Phase 3 | 2026-08-26 | NCT04544293 | |
| Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cowden disease, DNA repair disease, Li-Fraumeni syndrome, Neoplasms, Multiple Primary, Nutritional and Metabolic Diseases, hamartoma, hereditary disease, hereditary neoplastic syndrome, metabolic disease, neoplasm | Recruiting | Not stated | 2026-08-18 | NCT06888388 | |
| Cannabidiol Medication Intervention Trial | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 2 | 2026-07-31 | NCT06014424 | |
| Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents With Anxiety and Depression | anxiety disorder, depressive disorder, psychiatric disorder | Recruiting | Not applicable | 2026-06-22 | NCT06853587 | |
| Clinical Information System Impact on Hospitalized Patients With Chronic Disease | Arterial Occlusive Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, heart failure, kidney disorder, metabolic disease, myocardial ischemia, urinary system disorder, vascular disorder | Not yet recruiting | Not stated | 2026-05-27 | NCT07609381 | |
| Pharmacogenetic Supported Prescribing in Kids | Bipolar and Related Disorders, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, anxiety disorder, bipolar disorder, depressive disorder, mood disorder, psychiatric disorder | Active, not recruiting | Not applicable | 2026-05-12 | NCT04797364 | |
| Sleep Quality in Assisted-Living Residents | Parasomnias, nervous system disorder, psychiatric disorder, sleep disorder, sleep-wake disorder | Recruiting | Not stated | 2026-05-01 | NCT04400617 | |
| Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia | Apnea, Dyssomnias, Hypoxia, Hypoxia, Brain, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Signs and Symptoms, Signs and Symptoms, Respiratory, Sleep Disorders, Intrinsic, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, psychiatric disorder, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder, stroke disorder, vascular disorder | Recruiting | Phase 1 / Phase 2 | 2026-05-01 | NCT03255408 | |
| HNFO With or Without Helmet NIV for Oxygenation Support in Acute Respiratory Failure Pilot RCT | Acute Hypoxemic Respiratory Failure, Respiration Disorders, respiratory failure, respiratory system disorder | Active, not recruiting | Not applicable | 2026-03-16 | NCT05078034 | |
| Nabilone for Agitation Blinded Intervention Trial | Alzheimer disease, Chemically-Induced Disorders, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, brain disorder, cannabis dependence, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, substance-related disorder, tauopathy | Recruiting | Phase 3 | 2026-01-28 | NCT04516057 |